Provided by Tiger Fintech (Singapore) Pte. Ltd.

Adlai Nortye Biopharma Co. Ltd.

2.14
+0.09004.39%
Volume:1.93K
Turnover:4.16K
Market Cap:78.97M
PE:-0.92
High:2.20
Open:2.15
Low:2.14
Close:2.05
Loading ...
Feb 14, 2025

[Rev.]Annual Report

Form 20-F/A - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]: [Amend]
Jan 27, 2025

Correspondence

Form CORRESP - Correspondence
Jan 02, 2025

Correspondence

Form CORRESP - Correspondence
May 13, 2024

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Apr 19, 2024

Annual Report

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
Mar 04, 2024

Beneficial Ownership Change

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 15, 2024

Beneficial Ownership Change

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 15, 2024

Beneficial Ownership Change

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 15, 2024

Beneficial Ownership Change

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Jan 31, 2024

Beneficial Ownership Change

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Oct 13, 2023

Beneficial Ownership Change

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Sep 27, 2023

Correspondence

Form CORRESP - Correspondence
Sep 27, 2023

Correspondence

Form CORRESP - Correspondence
Sep 27, 2023

Correspondence

Form CORRESP - Correspondence
Sep 27, 2023

[Amend]Public Prospectus

Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
Sep 12, 2023

[Amend]Public Prospectus

Form F-1/A - Registration statement for certain foreign private issuers: [Amend]